Weill Medical College Of Cornell University
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1865-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://weill.cornell.edu
Comparison of Global, G-TL, & Cornell Media
Phase 4
Withdrawn
- Conditions
- Infertility
- Interventions
- Biological: Global vs. G-TL vs Cornell's C3 vs Cornell's C1/C2 media
- First Posted Date
- 2018-09-27
- Last Posted Date
- 2018-09-27
- Lead Sponsor
- Weill Medical College of Cornell University
- Registration Number
- NCT03687697
- Locations
- 🇺🇸
Center for Reproductive Medicine, New York, New York, United States
Daratumumab Plus Ibrutinib in Patients With Waldenstrӧm's Macroglobulinemia
Phase 2
Terminated
- Conditions
- Waldenstrom MacroglobulinemiaWaldenstrom's DiseaseWaldenström; HypergammaglobulinemiaWaldenstrom's Macroglobulinemia RefractoryWaldenstrom's Macroglobulinemia RecurrentWaldenstrom's Macroglobulinemia of Lymph NodesWaldenstrom's Macroglobulinaemia, Without Mention of Remission
- Interventions
- First Posted Date
- 2018-09-20
- Last Posted Date
- 2023-10-23
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 1
- Registration Number
- NCT03679624
- Locations
- 🇺🇸
Weill Cornell Medicine, New York, New York, United States
PSMA Imaging of Localized Prostate Cancer
- First Posted Date
- 2018-09-18
- Last Posted Date
- 2020-10-14
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 20
- Registration Number
- NCT03675451
- Locations
- 🇺🇸
Weill Cornell Medicine, New York, New York, United States
Quantitative Mapping of Substantia Nigra Iron in Parkinson's Disease (Stages I-IV, REM Sleep Behavior Disorder) and Controls
Phase 1
Completed
- Conditions
- REM Sleep Behavior DisorderHealthyParkinson Disease
- Interventions
- Drug: Ioflupane
- First Posted Date
- 2018-09-18
- Last Posted Date
- 2025-03-12
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 82
- Registration Number
- NCT03675282
- Locations
- 🇺🇸
Hospital for Special Surgery, New York, New York, United States
PRE-ProstAtectomy MRI-GuidEd Stereotactic Body RadioTherapy for High-Risk Prostate Cancer Trial (PREPARE SBRT)
Not Applicable
Active, not recruiting
- Conditions
- Prostate Cancer
- Interventions
- Radiation: Dose escalation
- First Posted Date
- 2018-09-10
- Last Posted Date
- 2025-02-24
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 35
- Registration Number
- NCT03663218
- Locations
- 🇺🇸
Weill Cornell Medicine, New York, New York, United States
PET Measures of CSF Clearance in Preclinical Alzheimer's Disease
Completed
- Conditions
- Mild Cognitive Impairment
- First Posted Date
- 2018-09-10
- Last Posted Date
- 2022-10-20
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 116
- Registration Number
- NCT03663387
- Locations
- 🇺🇸
Weill Cornell Medicine, New York, New York, United States
MRI-guided Stereotactic Body Radiotherapy (SBRT) With Simultaneous Integrated Boost for Prostate Cancer
Not Applicable
Completed
- Conditions
- Prostate Cancer
- Interventions
- Radiation: SIBRT
- First Posted Date
- 2018-09-10
- Last Posted Date
- 2021-01-05
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 30
- Registration Number
- NCT03664193
- Locations
- 🇺🇸
Weill Cornell Medicine, New York, New York, United States
Effects of Perampanel on Neurophysiology Test Perimeters
- First Posted Date
- 2018-08-31
- Last Posted Date
- 2023-07-03
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 12
- Registration Number
- NCT03653741
- Locations
- 🇺🇸
Neurophysiology Laboratory, New York, New York, United States
The CAPTURE Study: Validating a Unique COPD Case Finding Tool in Primary Care (Aim 2)
Completed
- Conditions
- Chronic Obstructive Pulmonary Disease (COPD)
- Interventions
- Other: Patient Opinion SurveysOther: On-site Practice AssessmentOther: Clinical Staff QuestionnairesOther: Modular online COPD EducationOther: COPD in Primary Care/CAPTURE Introduction Focus Groups
- First Posted Date
- 2018-08-31
- Last Posted Date
- 2023-06-22
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 196
- Registration Number
- NCT03653611
- Locations
- 🇺🇸
Duke University, Durham, North Carolina, United States
🇺🇸LANet, Los Angeles, California, United States
🇺🇸High Plains Research Network, Aurora, Colorado, United States
The LUCINDA Trial: LeUprolide Plus Cholinesterase Inhibition to Reduce Neurological Decline in Alzheimer's
Phase 2
Recruiting
- Conditions
- Mild Cognitive ImpairmentAlzheimer Disease
- Interventions
- Drug: Placebo
- First Posted Date
- 2018-08-28
- Last Posted Date
- 2025-05-13
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 180
- Registration Number
- NCT03649724
- Locations
- 🇺🇸
University of Miami Miller School of Medicine, Boca Raton, Florida, United States
🇺🇸Weill Medical College of Cornell University, New York, New York, United States
🇺🇸University of Wisconsin - Madison, Madison, Wisconsin, United States
© Copyright 2025. All Rights Reserved by MedPath